|
|
|||
, the gene encoding peroxisome-proliferatoractivated receptor
(PPAR
), which is rare, can yield corroborating and new insights into the metabolic syndrome. However, it is important to acknowledge that all reported cases of the metabolic syndrome involving heterozygous germ-line loss-of-function PPAR
mutations2,3,4,5 concurrently have familial partial lipodystrophy type 3 (FPLD3). Given the role of PPAR
in adipogenesis, it seems reasonable that adipose tissue is repartitioned from peripheral to central stores in patients with such mutations. This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |